On the 3rd week of each month, the Institute of Clinical and Translational Sciences invites inventors, scientists, and entrepreneurs to share lessons learned from taking ideas from the
On the 3rd week of each month, the Institute of Clinical and Translational Sciences invites inventors, scientists, and entrepreneurs to share lessons learned from taking ideas from the lab to the marketplace.
Join us to hear two innovators discuss their unique pathways from development to commercialization. Justin Sacks, a plastic surgeon, will talk about the “Mercury Patch,” a single-use disposable device for preventing pressure ulcers. Matthew MacEwan will discuss his development of the first resorbable synthetic nanofiber matrix approved for treatment of chronic wounds.
Justin Sacks, MD, MBA, FACS
Justin M. Sacks is the Shoenberg Professor and Chief, Division of Plastic and Reconstructive Surgery in the Department of Surgery at Washington University in St. Louis. He recently spent the last decade at Johns Hopkins School of Medicine where he was the Vice-Chair of Clinical Operations and Director of Oncological Reconstruction. His research focuses on advancements in the field of vascularized composite allotransplantation, tissue engineering and vascular perfusion assessment. His clinical interests include the reconstruction of all forms of acquired, oncological and traumatic defects ranging from the head and neck to the breast, chest, abdomen, pelvis and extremities. In 2016 he completed an MBA in medical service management at the Carey Business School at Johns Hopkins University. He is the co-founder of the Johns Hopkins Biotech Startup Lifesprout.
Matthew MacEwan, MD, PhD
Matthew MacEwan is the founder and chief scientific officer of Acera Surgical, Inc., a bioscience company developing and commercializing groundbreaking soft-tissue repair products. MacEwan is also an Assistant Professor of Neurological Surgery at Washington University. His laboratory is investigating strategies to improve nerve regeneration and is focused on the development of innovative technology targeting peripheral nerve/neuroprosthetic interfaces.
(Thursday) 4:00 pm - 5:00 pm
RSVPing is closed at this time.
Virtual Event Details
Event has already taken place!
Washington University School of Medicine